Assessing predictors of pulmonary sequel in COVID-19 patients through lung CT imaging; a two-month comprehensive evaluation DOI
Amir Behnam Kharazmi, Zeinab Khazaei Poul, Seyed Hamidreza Mirbehbahani

и другие.

Journal of Renal Endocrinology, Год журнала: 2024, Номер 10, С. e25180 - e25180

Опубликована: Янв. 1, 2024

Introduction: The emergence of COVID-19 has resulted in an unprecedented global health crisis. While acute respiratory symptoms are well-documented, there is growing concern regarding the long-term pulmonary effects survivors. Objectives: This study aimed to evaluate sequel patients referred Imam Hossein Hospital, Tehran, Iran, 2022. Patients and Methods: longitudinal involved 180 who recovered from at Hospital 2022, selected based on confirmed diagnoses resolution symptoms. Data were collected through a demographic questionnaire clinical checklist. Participants followed for two months, during which lung involvement was categorized as clear or non-clear, allowing evaluation associations between data with computed tomography (CT) outcomes. Results: Results indicated statistically significant correlation findings, including exceeding 30%, intensive care unit (ICU) admission necessity, intubation status, prolonged hospitalization duration non-clear status. Lung greater than 30% longer identified independent predictors adverse outcomes, odds ratios 2.30 2.47, respectively. Conclusion: highlights relationship findings outcomes patients, particularly emphasizing that critical complications.

Язык: Английский

Cardiovascular disease as part of Long COVID: a systematic review DOI
Vasiliki Tsampasian, Maria Bäck, Marco Bernardi

и другие.

European Journal of Preventive Cardiology, Год журнала: 2024, Номер unknown

Опубликована: Фев. 20, 2024

Long COVID syndrome has had a major impact on million patients' lives worldwide. The cardiovascular system is an important aspect of this multifaceted disease that may manifest in many ways. We have hereby performed narrative review order to identify the extent manifestations syndrome.

Язык: Английский

Процитировано

16

Systolic Pulmonary Artery Pressure as Long-Term Mortality Predictor in Elderly Critically Ill with Severe COVID-19 Pneumonia DOI Creative Commons
Marko Kurnik,

Helena Božič,

Matej Podbregar

и другие.

Viruses, Год журнала: 2025, Номер 17(2), С. 244 - 244

Опубликована: Фев. 11, 2025

Background: COVID-19 can cause acute pulmonary hypertension (PH), worsening outcomes in critically ill elderly patients. Point-of-care ultrasound (POCUS), assessing right ventricular hemodynamics, predicts short-term outcomes. This study examines the long-term impact of PH on mortality Methods: retrospective analyzed data from patients over 70 years old with severe pneumonia admitted to a mixed 25-bed, level 3 intensive care unit (ICU). POCUS focused systolic artery pressure (sPAP) at admission. Mortality was evaluated 1000 days post-admission. Results: The included 130 patients, comprising 30 survivors and 100 non-survivors, cumulative rate 77%. Non-survivors had significantly higher sPAP values (39.1 ± 12.8 vs. 30.4 9.2, p = 0.04), which were associated survival analysis. Conclusion: Acute reflected by elevated (sPAP), is strongly Early assessment via may help identify high-risk guide management strategies improve

Язык: Английский

Процитировано

0

Cardiopulmonary Long-Term Effects 30 Months after Severe COVID-19 Infection DOI
Josef Niebauer,

Ahmet Iscel,

Sarah Schedl

и другие.

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Long COVID and gut candidiasis: What is the existing relationship? DOI

Filippo Bistagnino,

Davide Pizzi,

Filippo Mantovani

и другие.

World Journal of Gastroenterology, Год журнала: 2024, Номер 30(37), С. 4104 - 4114

Опубликована: Сен. 26, 2024

Since the beginning of coronavirus disease (COVID) 2019 pandemic, thousands articles on topic have been published, and although there is a growing trend research another associated condition, long disease, important points still remain to be clarified in this respect. Robust evidence has suggested relevant link between new clinical discoveries molecular mechanisms that could with manifestations different signs symptoms involving cases COVID. However, one existing gaps requires further investigation concerns possible relationship gut candidiasis While recent studies also suggest an interplay occurrence these two conditions, it not yet fully clear how may happen, as well specifics regarding pathophysiological involved. In connection advent potential strengthening body supporting hypothesis COVID, better understanding presentation, pathophysiology management such should essential useful for both, additional advances towards more targeted appropriate case management. Knowing about signs, symptoms, complications COVID order effectively mitigate related burden provide higher quality care life affected population. light need outcomes, here we review discuss content aspects including its condition candidiasis, propositions future research.

Язык: Английский

Процитировано

2

Severe COVID-19 and its cardiopulmonary effects 6 and 18 months after hospital discharge DOI Creative Commons
Josef Niebauer,

A Iscel,

Sarah Schedl

и другие.

Frontiers in Cardiovascular Medicine, Год журнала: 2024, Номер 11

Опубликована: Март 5, 2024

Introduction SARS-CoV-2 infection affects the cardiopulmonary system in acute as well long-term phase. The aim of present study was to comprehensively assess symptoms and possible impairments 6 18 months after hospitalization for severe COVID-19 infection. Methods This prospective registry included patients with PCR-confirmed requiring hospitalization. Follow-up approximately post discharge comprised a detailed patient history, clinical examination, transthoracic echocardiography, electrocardiogram, cardiac magnetic resonance imaging (cMRI), chest computed tomography (CT) scan, pulmonary function test (PFT), six-minute walk (6MWT) laboratory panel. At time second follow-up visit at months, without pathologic findings during first were contacted by phone inquire about course their symptoms. In all other initial examinations repeated. Results Two hundred Patients, who hospitalized COVID-19, recruited study. Due dropouts performed 170 patients. A comparison between two visits showed following results: Six discharge, 73% 52% fulfilled criteria Long COVID fatigue being most common symptom (49%). Echocardiography an impaired left ventricular 8% which 80% returned normal. cMRI revealed pericardial effusion 17% resolved 47% 15 underwent control cMRI. Signs peri- or myocarditis 5% 4 attended studies. CT scans identified post-infectious residues 24%. 25 repeated 20% full recovery. Length in-hospital stay significant predictor persisting (95% CI: 1.005–1.12, p = 0.03). Conclusion Comparing prevalence decreased over time, but high burden remained. Structural functional abnormalities less frequent than portrayed symptoms, it thus remains challenge substantiate

Язык: Английский

Процитировано

1

What Remains up to 7 Months after Severe and Moderate Pneumonia in Non-Vaccinated Patients with Long COVID? Results of a CT Study DOI Open Access
Ewa Kurys-Denis, Anna Grzywa-Celińska, Katarzyna Podgórska

и другие.

Journal of Clinical Medicine, Год журнала: 2023, Номер 12(16), С. 5388 - 5388

Опубликована: Авг. 19, 2023

Background: There is a growing evidence of long-lasting lung changes after COVID-19. Our aim was to assess the degree injury and evaluate recovery process 4–7-month-non-vaccinated convalescent patients discharged from hospital moderate severe COVID-19 pneumonia, who presented with symptoms long-COVID. Methods: On control CT mean 5-month period, we classified determined prevalence residual radiological abnormalities in 39 symptomatic patients. To advancement persisting used total severity score (TSS) chest then correlated results clinical data. Results conclusions: follow-up images, 94.9% showed persistent abnormalities. The most frequent were ground-glass opacities (74.4%), reticular pattern (64.1%), fibrotic (53.8%), nodules (33.3%), bronchiectasis (15.4%), vascular enlargement (10.3%), cavitation (5.1%). median TSS 4.1 points (interquartile range 3), whereas 5.4 4.5). No significant differences observed between sex subgroups course groups. no association both scores initial disease, indicating that, 5 months pulmonary reduced similar stage severity.

Язык: Английский

Процитировано

2

INTERSEÇÃO VIRAL: ANÁLISE DOS EFEITOS NEUROLÓGICOS PÓS-COVID NO SISTEMA NERVOSO DOI Open Access
Aléxia Stefani Siqueira Zetum,

Danielle Ribeiro Campos da Silva,

Giulia Maria Giacinti

и другие.

Опубликована: Март 5, 2024

Процитировано

0

OS EFEITOS DA CL EM OUTROS SISTEMAS CORPORAIS DOI Open Access
Giulia Maria Giacinti, Aléxia Stefani Siqueira Zetum, Flávio dos Santos Alvarenga

и другие.

Опубликована: Март 5, 2024

Процитировано

0

INTRODUÇÃO DOI Open Access
Aléxia Stefani Siqueira Zetum,

Giulia Maria Giacinti,

Felipe Ataides Mion

и другие.

Опубликована: Март 5, 2024

Процитировано

0

COVID-19 E O SISTEMA IMUNOLÓGICO DOI Open Access
Aléxia Stefani Siqueira Zetum,

Giulia Maria Giacinti,

Yasmin Moreto Guaitolini

и другие.

Опубликована: Март 5, 2024

Процитировано

0